This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "New Agents on the Horizon in NHL and Myeloma - Targets Other Than CD3/CD20, New Constructs, and Trispecifics"

47 views
June 12, 2024

Chapters

Introduction & Bispecific Antibodies Overview

00:00

AZD0486: A Novel CD3/CD19 Bispecific Antibody

02:00

HPN217: Exploring Trispecific Antibodies in Myeloma

07:22

AFM13 & NK Cell Engagement in Lymphoma

10:30

Conclusions & Future Perspectives

13:14

Comments 0
Login to view comments. Click here to Login